Caitlin T. Fierheller

London, ENG EC1M6BQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.

Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.

Journal: Gynecologic oncology

Published: April 30, 2026

Health-related quality of life after risk-reducing hysterectomy (PRESCORES): a cross-sectional study.

Health-related quality of life after risk-reducing hysterectomy (PRESCORES): a cross-sectional study.

Journal: EClinicalMedicine

Published: February 15, 2026

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway.

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway.

Journal: NPJ breast cancer

Published: January 27, 2026

Consent model for tumour genetic testing in ovarian cancer.

Consent model for tumour genetic testing in ovarian cancer.

Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Published: December 01, 2025

Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis.

Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis.

Journal: American journal of obstetrics and gynecology

Published: October 21, 2025

The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers.

The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers.

Journal: International journal of molecular sciences

Published: October 03, 2025

Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer.

Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer.

Journal: JAMA network open

Published: September 16, 2025

P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery.

P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery.

Journal: Cancers

Published: September 11, 2025

Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention.

Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention.

Journal: JAMA oncology

Published: July 24, 2025

Co-occurring rare germline DNA repair gene variants in BRCA1/BRCA2 implicated hereditary breast cancer families.

Co-occurring rare germline DNA repair gene variants in BRCA1/BRCA2 implicated hereditary breast cancer families.

Journal: NPJ breast cancer

Published: June 23, 2025

Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis.

Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis.

Journal: American journal of obstetrics and gynecology

Published: January 14, 2025

Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada.

Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada.

Journal: JAMA network open

Published: September 12, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026